Global Covid-19 Vaccination Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	156 Pages	TechNavio	October, 2023	INF18250138

Best Price Guarantee
Price	from $2,500
Length	156 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18250138

Global Covid-19 Vaccination Market 2023-2027

The covid-19 vaccination market is forecasted to grow by USD -54598.89 million during 2022-2027, accelerating at a CAGR of -29.3% during the forecast period. The report on the covid-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of vaccination programs, emergence of new covid-19 variants, and expanded covid-19 vaccine eligibility.

Technavio's covid-19 vaccination market is segmented as below:

By Type

mRNA
Others

By Distribution Channel

Government entities
Hospitals and clinics
Others

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the rising r and d investment as one of the prime reasons driving the covid-19 vaccination market growth during the next few years. Also, launch of new covid-19 vaccines and adoption of technology and innovation in covid-19 vaccination market will lead to sizable demand in the market.

The report on the covid-19 vaccination market covers the following areas:

Covid-19 vaccination market sizing
Covid-19 vaccination market forecast
Covid-19 vaccination market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading covid-19 vaccination market vendors that include AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd.. Also, the covid-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary €“ Chart on Market Overview; Exhibit 02: Executive Summary €“ Data Table on Market Overview; Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics; Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type; Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel; Exhibit 07: Executive Summary €“ Chart on Incremental Growth; Exhibit 08: Executive Summary €“ Data Table on Incremental Growth; Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Five Forces Analysis: 4.1 Five forces summary; Exhibit 18: Five forces analysis - Comparison between 2022 and 2027; 4.2 Bargaining power of buyers; Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; 4.3 Bargaining power of suppliers; Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; 4.4 Threat of new entrants; Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027; 4.5 Threat of substitutes; Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027; 4.6 Threat of rivalry; Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027; 4.7 Market condition; Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by Type: 5.1 Market segments; Exhibit 25: Chart on Type - Market share 2022-2027 (%); Exhibit 26: Data Table on Type - Market share 2022-2027 (%); 5.2 Comparison by Type; Exhibit 27: Chart on Comparison by Type; Exhibit 28: Data Table on Comparison by Type; 5.3 mRNA - Market size and forecast 2022-2027; Exhibit 29: Chart on mRNA - Market size and forecast 2022-2027 ($ million); Exhibit 30: Data Table on mRNA - Market size and forecast 2022-2027 ($ million); Exhibit 31: Chart on mRNA - Year-over-year growth 2022-2027 (%); Exhibit 32: Data Table on mRNA - Year-over-year growth 2022-2027 (%); 5.4 Others - Market size and forecast 2022-2027; Exhibit 33: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 34: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 35: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on Others - Year-over-year growth 2022-2027 (%); 5.5 Market opportunity by Type; Exhibit 37: Market opportunity by Type ($ million); Exhibit 38: Data Table on Market opportunity by Type ($ million)
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Exhibit 39: Chart on Distribution Channel - Market share 2022-2027 (%); Exhibit 40: Data Table on Distribution Channel - Market share 2022-2027 (%); 6.2 Comparison by Distribution Channel; Exhibit 41: Chart on Comparison by Distribution Channel; Exhibit 42: Data Table on Comparison by Distribution Channel; 6.3 Government entities - Market size and forecast 2022-2027; Exhibit 43: Chart on Government entities - Market size and forecast 2022-2027 ($ million); Exhibit 44: Data Table on Government entities - Market size and forecast 2022-2027 ($ million); Exhibit 45: Chart on Government entities - Year-over-year growth 2022-2027 (%); Exhibit 46: Data Table on Government entities - Year-over-year growth 2022-2027 (%); 6.4 Hospitals and clinics - Market size and forecast 2022-2027; Exhibit 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million); Exhibit 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million); Exhibit 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%); 6.5 Others - Market size and forecast 2022-2027; Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.6 Market opportunity by Distribution Channel; Exhibit 55: Market opportunity by Distribution Channel ($ million); Exhibit 56: Data Table on Market opportunity by Distribution Channel ($ million)
7 Customer Landscape: 7.1 Customer landscape overview; Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Exhibit 58: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 59: Data Table on Market share By Geographical Landscape 2022-2027 (%); 8.2 Geographic comparison; Exhibit 60: Chart on Geographic comparison; Exhibit 61: Data Table on Geographic comparison; 8.3 North America - Market size and forecast 2022-2027; Exhibit 62: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 63: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 64: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 65: Data Table on North America - Year-over-year growth 2022-2027 (%); 8.4 Asia - Market size and forecast 2022-2027; Exhibit 66: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 67: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 68: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 69: Data Table on Asia - Year-over-year growth 2022-2027 (%); 8.5 Europe - Market size and forecast 2022-2027; Exhibit 70: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 71: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 72: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 73: Data Table on Europe - Year-over-year growth 2022-2027 (%); 8.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 74: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 75: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 76: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 77: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 8.7 US - Market size and forecast 2022-2027; Exhibit 78: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 79: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 80: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 81: Data Table on US - Year-over-year growth 2022-2027 (%); 8.8 China - Market size and forecast 2022-2027; Exhibit 82: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 83: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 84: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 85: Data Table on China - Year-over-year growth 2022-2027 (%); 8.9 Japan - Market size and forecast 2022-2027; Exhibit 86: Chart on Japan - Market size and forecast 2022-2027 ($ million); Exhibit 87: Data Table on Japan - Market size and forecast 2022-2027 ($ million); Exhibit 88: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibit 89: Data Table on Japan - Year-over-year growth 2022-2027 (%); 8.10 UK - Market size and forecast 2022-2027; Exhibit 90: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 91: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 92: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 93: Data Table on UK - Year-over-year growth 2022-2027 (%); 8.11 Germany - Market size and forecast 2022-2027; Exhibit 94: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 95: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 96: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 97: Data Table on Germany - Year-over-year growth 2022-2027 (%); 8.12 Market opportunity By Geographical Landscape; Exhibit 98: Market opportunity By Geographical Landscape ($ million); Exhibit 99: Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Trends: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Exhibit 100: Impact of drivers and challenges in 2022 and 2027; 9.4 Market trends
10 Vendor Landscape: 10.1 Overview; 10.2 Vendor landscape; Exhibit 101: Overview on Criticality of inputs and Factors of differentiation; 10.3 Landscape disruption; Exhibit 102: Overview on factors of disruption; 10.4 Industry risks; Exhibit 103: Impact of key risks on business
11 Vendor Analysis: 11.1 Vendors covered; Exhibit 104: Vendors covered; 11.2 Market positioning of vendors; Exhibit 105: Matrix on vendor position and classification; 11.3 AstraZeneca Plc; Exhibit 106: AstraZeneca Plc - Overview; Exhibit 107: AstraZeneca Plc - Product / Service; Exhibit 108: AstraZeneca Plc - Key news; Exhibit 109: AstraZeneca Plc - Key offerings; 11.4 Bharat Biotech Ltd.; Exhibit 110: Bharat Biotech Ltd. - Overview; Exhibit 111: Bharat Biotech Ltd. - Product / Service; Exhibit 112: Bharat Biotech Ltd. - Key news; Exhibit 113: Bharat Biotech Ltd. - Key offerings; 11.5 CureVac AG; Exhibit 114: CureVac AG - Overview; Exhibit 115: CureVac AG - Key offerings; 11.6 Emergent BioSolutions Inc.; Exhibit 116: Emergent BioSolutions Inc. - Overview; Exhibit 117: Emergent BioSolutions Inc. - Product / Service; Exhibit 118: Emergent BioSolutions Inc. - Key news; Exhibit 119: Emergent BioSolutions Inc. - Key offerings; 11.7 Genexine Inc.; Exhibit 120: Genexine Inc. - Overview; Exhibit 121: Genexine Inc. - Product / Service; Exhibit 122: Genexine Inc. - Key offerings; 11.8 Inovio Pharmaceuticals Inc.; Exhibit 123: Inovio Pharmaceuticals Inc. - Overview; Exhibit 124: Inovio Pharmaceuticals Inc. - Product / Service; Exhibit 125: Inovio Pharmaceuticals Inc. - Key news; Exhibit 126: Inovio Pharmaceuticals Inc. - Key offerings; 11.9 Johnson and Johnson; Exhibit 127: Johnson and Johnson - Overview; Exhibit 128: Johnson and Johnson - Business segments; Exhibit 129: Johnson and Johnson - Key news; Exhibit 130: Johnson and Johnson - Key offerings; Exhibit 131: Johnson and Johnson - Segment focus; 11.10 Moderna Inc.; Exhibit 132: Moderna Inc. - Overview; Exhibit 133: Moderna Inc. - Product / Service; Exhibit 134: Moderna Inc. - Key offerings; 11.11 Novavax Inc.; Exhibit 135: Novavax Inc. - Overview; Exhibit 136: Novavax Inc. - Product / Service; Exhibit 137: Novavax Inc. - Key offerings; 11.12 Pfizer Inc.; Exhibit 138: Pfizer Inc. - Overview; Exhibit 139: Pfizer Inc. - Product / Service; Exhibit 140: Pfizer Inc. - Key news; Exhibit 141: Pfizer Inc. - Key offerings; 11.13 Serum Institute of India Pvt. Ltd.; Exhibit 142: Serum Institute of India Pvt. Ltd. - Overview; Exhibit 143: Serum Institute of India Pvt. Ltd. - Product / Service; Exhibit 144: Serum Institute of India Pvt. Ltd. - Key offerings; 11.14 Shenzhen Kangtai Biological Products Co. Ltd.; Exhibit 145: Shenzhen Kangtai Biological Products Co. Ltd. - Overview; Exhibit 146: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service; Exhibit 147: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings; 11.15 Sinovac Biotech Ltd.; Exhibit 148: Sinovac Biotech Ltd. - Overview; Exhibit 149: Sinovac Biotech Ltd. - Product / Service; Exhibit 150: Sinovac Biotech Ltd. - Key offerings; 11.16 Tadbir innovation pharmaceutical Co.; Exhibit 151: Tadbir innovation pharmaceutical Co. - Overview; Exhibit 152: Tadbir innovation pharmaceutical Co. - Product / Service; Exhibit 153: Tadbir innovation pharmaceutical Co. - Key offerings; 11.17 Zydus Lifesciences Ltd.; Exhibit 154: Zydus Lifesciences Ltd. - Overview; Exhibit 155: Zydus Lifesciences Ltd. - Business segments; Exhibit 156: Zydus Lifesciences Ltd. - Key offerings; Exhibit 157: Zydus Lifesciences Ltd. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Exhibit 158: Inclusions checklist; Exhibit 159: Exclusions checklist; 12.3 Currency conversion rates for US$; Exhibit 160: Currency conversion rates for US$; 12.4 Research methodology; Exhibit 161: Research methodology; Exhibit 162: Validation techniques employed for market sizing; Exhibit 163: Information sources; 12.5 List of abbreviations; Exhibit 164: List of abbreviations
Exhibits:: Exhibits1: Executive Summary €“ Chart on Market Overview; Exhibits2: Executive Summary €“ Data Table on Market Overview; Exhibits3: Executive Summary €“ Chart on Global Market Characteristics; Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type; Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary €“ Chart on Incremental Growth; Exhibits8: Executive Summary €“ Data Table on Incremental Growth; Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Five forces analysis - Comparison between 2022 and 2027; Exhibits19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; Exhibits20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; Exhibits21: Threat of new entrants €“ Impact of key factors in 2022 and 2027; Exhibits22: Threat of substitutes €“ Impact of key factors in 2022 and 2027; Exhibits23: Threat of rivalry €“ Impact of key factors in 2022 and 2027; Exhibits24: Chart on Market condition - Five forces 2022 and 2027; Exhibits25: Chart on Type - Market share 2022-2027 (%); Exhibits26: Data Table on Type - Market share 2022-2027 (%); Exhibits27: Chart on Comparison by Type; Exhibits28: Data Table on Comparison by Type; Exhibits29: Chart on mRNA - Market size and forecast 2022-2027 ($ million); Exhibits30: Data Table on mRNA - Market size and forecast 2022-2027 ($ million); Exhibits31: Chart on mRNA - Year-over-year growth 2022-2027 (%); Exhibits32: Data Table on mRNA - Year-over-year growth 2022-2027 (%); Exhibits33: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits34: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits35: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits37: Market opportunity by Type ($ million); Exhibits38: Data Table on Market opportunity by Type ($ million); Exhibits39: Chart on Distribution Channel - Market share 2022-2027 (%); Exhibits40: Data Table on Distribution Channel - Market share 2022-2027 (%); Exhibits41: Chart on Comparison by Distribution Channel; Exhibits42: Data Table on Comparison by Distribution Channel; Exhibits43: Chart on Government entities - Market size and forecast 2022-2027 ($ million); Exhibits44: Data Table on Government entities - Market size and forecast 2022-2027 ($ million); Exhibits45: Chart on Government entities - Year-over-year growth 2022-2027 (%); Exhibits46: Data Table on Government entities - Year-over-year growth 2022-2027 (%); Exhibits47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million); Exhibits48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million); Exhibits49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits55: Market opportunity by Distribution Channel ($ million); Exhibits56: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits58: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits59: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits60: Chart on Geographic comparison; Exhibits61: Data Table on Geographic comparison; Exhibits62: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits63: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits64: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits65: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits66: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits67: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits68: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits69: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits70: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits71: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits72: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits73: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits74: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits75: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits76: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits77: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits78: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits79: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits80: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits81: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits82: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits83: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits84: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits85: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits86: Chart on Japan - Market size and forecast 2022-2027 ($ million); Exhibits87: Data Table on Japan - Market size and forecast 2022-2027 ($ million); Exhibits88: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibits89: Data Table on Japan - Year-over-year growth 2022-2027 (%); Exhibits90: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits91: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits92: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits93: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits94: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits95: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits96: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits97: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits98: Market opportunity By Geographical Landscape ($ million); Exhibits99: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits100: Impact of drivers and challenges in 2022 and 2027; Exhibits101: Overview on Criticality of inputs and Factors of differentiation; Exhibits102: Overview on factors of disruption; Exhibits103: Impact of key risks on business; Exhibits104: Vendors covered; Exhibits105: Matrix on vendor position and classification; Exhibits106: AstraZeneca Plc - Overview; Exhibits107: AstraZeneca Plc - Product / Service; Exhibits108: AstraZeneca Plc - Key news; Exhibits109: AstraZeneca Plc - Key offerings; Exhibits110: Bharat Biotech Ltd. - Overview; Exhibits111: Bharat Biotech Ltd. - Product / Service; Exhibits112: Bharat Biotech Ltd. - Key news; Exhibits113: Bharat Biotech Ltd. - Key offerings; Exhibits114: CureVac AG - Overview; Exhibits115: CureVac AG - Key offerings; Exhibits116: Emergent BioSolutions Inc. - Overview; Exhibits117: Emergent BioSolutions Inc. - Product / Service; Exhibits118: Emergent BioSolutions Inc. - Key news; Exhibits119: Emergent BioSolutions Inc. - Key offerings; Exhibits120: Genexine Inc. - Overview; Exhibits121: Genexine Inc. - Product / Service; Exhibits122: Genexine Inc. - Key offerings; Exhibits123: Inovio Pharmaceuticals Inc. - Overview; Exhibits124: Inovio Pharmaceuticals Inc. - Product / Service; Exhibits125: Inovio Pharmaceuticals Inc. - Key news; Exhibits126: Inovio Pharmaceuticals Inc. - Key offerings; Exhibits127: Johnson and Johnson - Overview; Exhibits128: Johnson and Johnson - Business segments; Exhibits129: Johnson and Johnson - Key news; Exhibits130: Johnson and Johnson - Key offerings; Exhibits131: Johnson and Johnson - Segment focus; Exhibits132: Moderna Inc. - Overview; Exhibits133: Moderna Inc. - Product / Service; Exhibits134: Moderna Inc. - Key offerings; Exhibits135: Novavax Inc. - Overview; Exhibits136: Novavax Inc. - Product / Service; Exhibits137: Novavax Inc. - Key offerings; Exhibits138: Pfizer Inc. - Overview; Exhibits139: Pfizer Inc. - Product / Service; Exhibits140: Pfizer Inc. - Key news; Exhibits141: Pfizer Inc. - Key offerings; Exhibits142: Serum Institute of India Pvt. Ltd. - Overview; Exhibits143: Serum Institute of India Pvt. Ltd. - Product / Service; Exhibits144: Serum Institute of India Pvt. Ltd. - Key offerings; Exhibits145: Shenzhen Kangtai Biological Products Co. Ltd. - Overview; Exhibits146: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service; Exhibits147: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings; Exhibits148: Sinovac Biotech Ltd. - Overview; Exhibits149: Sinovac Biotech Ltd. - Product / Service; Exhibits150: Sinovac Biotech Ltd. - Key offerings; Exhibits151: Tadbir innovation pharmaceutical Co. - Overview; Exhibits152: Tadbir innovation pharmaceutical Co. - Product / Service; Exhibits153: Tadbir innovation pharmaceutical Co. - Key offerings; Exhibits154: Zydus Lifesciences Ltd. - Overview; Exhibits155: Zydus Lifesciences Ltd. - Business segments; Exhibits156: Zydus Lifesciences Ltd. - Key offerings; Exhibits157: Zydus Lifesciences Ltd. - Segment focus; Exhibits158: Inclusions checklist; Exhibits159: Exclusions checklist; Exhibits160: Currency conversion rates for US$; Exhibits161: Research methodology; Exhibits162: Validation techniques employed for market sizing; Exhibits163: Information sources; Exhibits164: List of abbreviations